Mesenchymal stem cells in autoimmune diseases: Hype or hope?

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Scherer, Hans U ^a,b   van Pel, Melissa ^a   Toes, René E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; INDOLEAMINE 2,3 DIOXYGENASE; NITRIC OXIDE; PROGRAMMED DEATH 1 LIGAND 1; PROSTAGLANDIN E2;

ALLOGENEIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CELLULAR IMMUNITY; DISEASE COURSE; EDITORIAL; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; MESENCHYMAL STEM CELL; RHEUMATIC DISEASE; ANIMAL; ARTHRITIS; AUTOIMMUNE DISEASE; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; T-LYMPHOCYTES;

EID: 77953639007     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3036     Document Type: Editorial

References (11)

1. Schurgers E, Kelchtermans H, Mitera T, Geboes L, Matthys P. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther 2010, 12:R31. 10.1186/ar2939, 2875665, 20175883.
2. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506. 10.1182/blood-2007-02-069716, 17664353.
3. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006, 108:2114-2120. 10.1182/blood-2005-11-011650, 1895546, 16690970.
4. Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Biol Blood Marrow Transplant 2008, 14:1031-1038. 10.1016/j.bbmt.2008.06.016, 18721766.
5. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415. 10.1126/science.285.5426.412, 10411505.
6. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O, . Developmental Committee of the European Group for Blood and Marrow Transplantation Mesenchymal stem cells for treatment of steroidresistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586. 10.1016/S0140-6736(08)60690-X, 18468541, Developmental Committee of the European Group for Blood and Marrow Transplantation.
7. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005, 48:1416-1423. 10.1007/s10350-005-0052-6, 15933795.
8. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noël D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005, 52:1595-1603. 10.1002/art.21012, 15880818.
9. Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM. Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation. Blood 2005, 105:2991-2994. 10.1182/blood-2004-09-3715, 15604221.
10. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, Mönckeberg G, Figueroa FE. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 2010, 19:317-322. 10.1177/0961203309348983, 19919974.
11. Christopeit M, Schendel M, Foll J, Muller LP, Keysser G, Behre G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 2008, 22:1062-1064. 10.1038/sj.leu.2404996, 17972956.